Its features of impaired insulin signaling and inflammation were also observed in AD patients, along with lower levels of insulin in cerebrospinal fluid and reduced activity of brain insulin-receptor (De Felice, 2013; Greene et al., 2015; Lin, 2008; Rani et al., 2016). The gene discussed is INS; the disease is Alzheimer disease.